These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3885674)
1. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. Conway SP; Miller MG; Ramsden C; Littlewood JM Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674 [TBL] [Abstract][Full Text] [Related]
2. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis. Gold R; Overmeyer A; Knie B; Fleming PC; Levison H Pediatr Infect Dis; 1985; 4(2):172-7. PubMed ID: 3885181 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin. Schaad UB; Desgrandchamps D; Kraemer R Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103 [TBL] [Abstract][Full Text] [Related]
4. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis. Parry MF; Neu HC J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276 [TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients. Jansen W; Schwarz A Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127 [TBL] [Abstract][Full Text] [Related]
6. Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis. Penketh AR; Hodson ME; Batten JC Br J Dis Chest; 1983 Apr; 77(2):179-84. PubMed ID: 6871085 [TBL] [Abstract][Full Text] [Related]
7. Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosis. Jackson MA; Kusmiesz H; Shelton S; Prestidge C; Kramer RI; Nelson JD Pediatr Infect Dis; 1986; 5(4):440-3. PubMed ID: 3725655 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis. Jewett CV; Ledbetter J; Lyrene RK; Brasfield DM; Tiller RE J Pediatr; 1985 Apr; 106(4):669-72. PubMed ID: 3845095 [No Abstract] [Full Text] [Related]
9. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin. Parry MF; Neu HC; Merlino M; Gaerlan PF; Ores CN; Denning CR J Pediatr; 1977 Jan; 90(1):144-8. PubMed ID: 401521 [TBL] [Abstract][Full Text] [Related]
10. Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis. Caplan DB; Buchanan CN Rev Infect Dis; 1984; 6 Suppl 3():S705-10. PubMed ID: 6443771 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli. Parry MF; Neu HC Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895 [TBL] [Abstract][Full Text] [Related]
12. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Taneja A; Murphy P; Goldmann DA J Infect Dis; 1983 Mar; 147(3):559-67. PubMed ID: 6339649 [TBL] [Abstract][Full Text] [Related]
13. Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis. Martin AJ; Smalley CA; George RH; Healing DE; Anderson CM Arch Dis Child; 1980 Aug; 55(8):604-7. PubMed ID: 7436516 [TBL] [Abstract][Full Text] [Related]
14. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Gappa M; Steinkamp G; Tümmler B; von der Hardt H Scand J Gastroenterol Suppl; 1988; 143():74-6. PubMed ID: 3164515 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis. McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Goldmann DA J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602 [TBL] [Abstract][Full Text] [Related]
16. Azlocillin in cystic fibrosis. Malmborg AS; Alfredsson H; Strandvik B Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681 [TBL] [Abstract][Full Text] [Related]
17. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Regelmann WE; Elliott GR; Warwick WJ; Clawson CC Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):914-21. PubMed ID: 2109558 [TBL] [Abstract][Full Text] [Related]
18. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153 [TBL] [Abstract][Full Text] [Related]